Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
01 1Strides Arcolab International Limited
02 2ACCORD HEALTHCARE LIMITED
03 1Accord Healthcare Slu
04 2BAXTER SpA
05 2EBEWE Pharma Ges.m.b.H Nfg. KG
06 1Ebewe Pharma Ges.M.B.H.Nfg.Kg
07 1MEDA PHARMA SpA
08 1Meda - Asker
09 1Meda Ab
10 1Mylan Hospital As
11 1Mylan Ire Healthcare Limited
12 2SANDOZ SpA
13 1Sandoz Pharmaceuticals Sa
01 11Mitoxantrone
02 2Mitoxantrone Hydrochloride
03 4Mitoxantronhydroklorid
01 2Concentrate For Infusion Solution
02 5Concentrate For Solution For Infusion
03 3Concentrate to the infusion fluid
04 3Mitoxantrone 10Mg 5Ml 1 Units Parenteral Use
05 4Mitoxantrone 20Mg 10Ml 1 Units Parenteral Use
01 7Italy
02 3Norway
03 3Spain
04 4Sweden
01 3Mitoxantron Ebewe
02 1Mitoxantron Sandoz
03 1Mitoxantrona Accord
04 4Mitoxantrone
05 1Mitoxantrone Mylan
06 1Mitoxantrone Strides
07 4Novantrone
08 2Onkotrone
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Regulatory Info : Deregistered
Registration Country : Sweden
Brand Name : Mitoxantrone Strides
Dosage Form : Concentrate For Solution For Infusion
Dosage Strength : 2mg/ml
Packaging :
Approval Date : 05/06/2013
Application Number : 20110513000016
Regulatory Info : Deregistered
Registration Country : Sweden
Regulatory Info :
Registration Country : Italy
Brand Name : Mitoxantrone
Dosage Form : Mitoxantrone 10Mg 5Ml 1 Units Parenteral Use
Dosage Strength : 1 vial EV 10 mg 5 ml 2 mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Mitoxantrone
Dosage Form : Mitoxantrone 20Mg 10Ml 1 Units Parenteral Use
Dosage Strength : 1 vial EV 20 mg 10 ml 2 mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Onkotrone
Dosage Form : Mitoxantrone 10Mg 5Ml 1 Units Parenteral Use
Dosage Strength : 1 vial EV 10 mg 5 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Onkotrone
Dosage Form : Mitoxantrone 20Mg 10Ml 1 Units Parenteral Use
Dosage Strength : 1 vial EV 20 mg 10 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Novantrone
Dosage Form : Mitoxantrone 20Mg 10Ml 1 Units Parenteral Use
Dosage Strength : 1 bottle EV 20 mg 10 ml 2 mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Mitoxantrone
Dosage Form : Mitoxantrone 10Mg 5Ml 1 Units Parenteral Use
Dosage Strength : 1 bottle EV 10 mg 5 ml 2 mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Mitoxantrone
Dosage Form : Mitoxantrone 20Mg 10Ml 1 Units Parenteral Use
Dosage Strength : 1 bottle EV 20 mg 10 ml 2 mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Norway
Brand Name : Mitoxantron Ebewe
Dosage Form : Concentrate to the infusion fluid
Dosage Strength : 2 mg/ml
Packaging : Hood glass
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Norway
Brand Name : Mitoxantron Ebewe
Dosage Form : Concentrate to the infusion fluid
Dosage Strength : 2 mg/ml
Packaging : Hood glass
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
